Puri Raj K. 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 6, 2026

AI-generated summary of this filing

Updated Mar 6, 2026

IOVANCE CRO Puri Raj K. Receives Award of 39,059 Shares

What Happened

Puri Raj K., Chief Regulatory Officer of Iovance Biotherapeutics (IOVA), had 39,059 restricted stock units (RSUs) convert into common stock on March 5, 2026. The gross market value of the vested shares was about $178,890 (39,059 × $4.58 per share).
To satisfy mandatory tax withholding, 18,360 shares were withheld by the issuer (reported as a payment of tax liability) valued at about $84,089. This withholding was not an open-market sale. The reporting person retained 20,699 shares after withholding (net value ≈ $94,801).
Transaction codes: M = exercise/conversion of derivative (RSU settlement); F = payment of exercise price or tax liability (shares withheld for taxes).

Key Details

Transaction date: March 5, 2026; Form 4 filed March 6, 2026 (timely).
Prices reported: conversion recorded at $0.00 (RSU settlement); per-share market price for withholding = $4.58.
Shares acquired on conversion: 39,059. Shares withheld for taxes: 18,360 (value ≈ $84,089). Shares retained after withholding: 20,699.
Notable footnotes: RSUs vested on the transaction date (each RSU = one share); withheld shares satisfy mandatory tax withholding and are not an open-market sale. Remaining RSUs from the March 5, 2025 grant will vest in equal quarterly installments.

Context

This was a routine RSU vesting event (settlement of derivative awards), not a cash purchase or open-market sale. The key signal to investors is limited: the insider received equity through compensation and had shares withheld to cover taxes.
No indication of a 10b5-1 plan or a gift; the filing appears timely.

Form 4

Period: 2026-03-05

Chief Regulatory Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-03-05+39,059→ 257,590 total
Tax Payment
Common Stock
[F2][F3]
2026-03-05$4.58/sh−18,360$84,089→ 239,230 total
Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]
2026-03-05−39,059→ 78,131 total
→ Common stock (39,059 underlying)

Footnotes (6)

[F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
[F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
[F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
[F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
[F5]The remaining RSUs will vest in equal quarterly installments.
[F6]Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Signature

/s/ Raj K. Puri|2026-03-06

1 file